» Articles » PMID: 25424699

Novel Mutations in the RB1 Gene from Chinese Families with a History of Retinoblastoma

Overview
Journal Tumour Biol
Publisher Sage Publications
Specialty Oncology
Date 2014 Nov 27
PMID 25424699
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Retinoblastoma is an aggressive eye cancer that develops during infancy and is divided into two clinical types, sporadic and heritable. RB1 has been identified as the only pathological gene responsible for heritable retinoblastoma. Here, we identified 11 RB1 germline mutations in the Han pedigrees of 17 bilateral retinoblastoma patients from China. Four mutations were nonsense mutations, five were splice site mutations, and two resulted in a frame shift due to an insertion or a deletion. Three of the mutations had not been previously reported, and the p.Q344L mutation occurred in two generations of retinoblastoma patients. We investigated phenotypic-genotypic relationships for the novel mutations and showed that these mutations affected the expression, location, and function of the retinoblastoma protein. Abnormal protein localization was observed after transfection of the mutant genes. In addition, changes in the cell cycle distribution and apoptosis rates were observed when the Saos-2 cell line was transfected with plasmids encoding the mutant RB1 genes. Our findings expand the spectrum of known RB1 mutations and will benefit the investigation of RB1 mutation hotspots. Genetic counseling can be offered to families with heritable RB1 mutations.

Citing Articles

RB1 screening of retinoblastoma patients in Sri Lanka using targeted next generation sequencing (NGS) and gene ratio analysis copy enumeration PCR (GRACE-PCR).

Kugalingam N, Silva D, Abeysekera H, Nanayakkara S, Tirimanne S, Ranaweera D BMC Med Genomics. 2023; 16(1):279.

PMID: 37932687 PMC: 10626775. DOI: 10.1186/s12920-023-01721-6.


Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens?.

El Nachef L, Berthel E, Ferlazzo M, Le Reun E, Al-Choboq J, Restier-Verlet J Cancers (Basel). 2022; 14(24).

PMID: 36551628 PMC: 9776478. DOI: 10.3390/cancers14246141.


Retinoblastoma genetics screening and clinical management.

Gupta H, Malaichamy S, Mallipatna A, Murugan S, Jeyabalan N, Babu V BMC Med Genomics. 2021; 14(1):188.

PMID: 34294096 PMC: 8296631. DOI: 10.1186/s12920-021-01034-6.


Study of Cinobufagin as a Promising Anticancer Agent in Uveal Melanoma Through Intrinsic Apoptosis Pathway.

Zhang L, Huang X, Guo T, Wang H, Fan H, Fang L Front Oncol. 2020; 10:325.

PMID: 32300551 PMC: 7142239. DOI: 10.3389/fonc.2020.00325.


Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counselling.

Tomar S, Sethi R, Sundar G, Quah T, Quah B, Lai P PLoS One. 2017; 12(6):e0178776.

PMID: 28575107 PMC: 5456385. DOI: 10.1371/journal.pone.0178776.


References
1.
Isaac C, Francis S, Martens A, Julian L, Seifried L, Erdmann N . The retinoblastoma protein regulates pericentric heterochromatin. Mol Cell Biol. 2006; 26(9):3659-71. PMC: 1447412. DOI: 10.1128/MCB.26.9.3659-3671.2006. View

2.
Dyson N . The regulation of E2F by pRB-family proteins. Genes Dev. 1998; 12(15):2245-62. DOI: 10.1101/gad.12.15.2245. View

3.
Ali M, Parsam V, Honavar S, Kannabiran C, Vemuganti G, Reddy V . RB1 gene mutations in retinoblastoma and its clinical correlation. Saudi J Ophthalmol. 2013; 24(4):119-23. PMC: 3729507. DOI: 10.1016/j.sjopt.2010.05.003. View

4.
Cowell J, Smith T, Bia B . Frequent constitutional C to T mutations in CGA-arginine codons in the RB1 gene produce premature stop codons in patients with bilateral (hereditary) retinoblastoma. Eur J Hum Genet. 1994; 2(4):281-90. DOI: 10.1159/000472372. View

5.
Zhao J, Li S, Shi J, Wang N . Clinical presentation and group classification of newly diagnosed intraocular retinoblastoma in China. Br J Ophthalmol. 2011; 95(10):1372-5. DOI: 10.1136/bjo.2010.191130. View